1. Mellors, J., Steigbigl, R. and Gulick, R.: Antiretroviral activity of the oral protease inhibitor, MK-639, in p24 antigenemic HIV-1 infected patients with < 500 CD4/mm3. Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy, California, p. 235, 1995.
2. Crystalluria and urinary tract abnormalities associated with indinavir;Kopp;Ann. Int. Med.,1997
3. Indinavir Sulfate,1996
4. Protease inhibitors and urolithiasis;Sutherland;J. Urol.,1997
5. HIV-1 protease inhibitors. A review for clinicians;Deeks;J.A.M.A.,1997